Cardiovascular intubation responses with Airway Scope and Macintosh laryngoscope

suitable regulatory or centralised testing body. We are very much aware that many new airway devices have entered the market over the last 20 years, and wish to see this continued. We are able to offer industry, via DAS’s existing network of research-active anaesthetists, a reliable platform to conduct the trials generating the published evidence. We have always done so in the past and essentially the NHS has provided this service for free. However, the changed landscape of biomedical research means that we now have to organise ourselves differently, and such services now have to come at a modest cost. There is no compulsion for any manufacturer to use the DAS network, especially if they are concerned about our costs, neutrality, confidentiality, conflicts of interest [4], or research credentials. If there are any causes for concern then manufacturers are free to go elsewhere to conduct their trials. However, we reiterate the recommendation with which Shaikh and Robinson agree – that where an airway device lacks any published clinical trial evidence, no anaesthetist should use or purchase it.